Tag: MINDACT

Endocrine therapy response provides information on need of adjuvant chemotherapy

Presented By
Prof. Oleg Gluz, Breast Center Niederrhein, Germany
Trial
Phase 3, ADAPTcycle
Conference
SABCS 2023
Type
News article

11 January 2024 14:58

SABCS 2021 Focus in Genomic Profiling

Presented By
Dr Rachel Giles, Medicom
Conference
SABCS 2021

17 February 2022 11:10

Excellent prognosis for breast cancer patients with ultra-low-risk gene signature

Presented By
Dr Josephine Lopes Cardozo, Netherlands Cancer Institute, the Netherlands
Trial
Phase 3, MINDACT
Conference
ASCO 2021
Type
Peer-reviewed article

12 August 2021 23:45

Tamoxifen monotherapy may mean undertreatment for some luminal breast cancer patients

Trial
MINDACT, TAILORx
Conference
SABCS 2019
Type
Peer-reviewed article

13 February 2020 10:01

Gene expression signatures

Trial
MINDACT, TAILOR-X, PLAN-B
Conference
BCC 2019
Type
Peer-reviewed article

21 May 2019 18:16
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com